Galectin-1, human recombinant protein
Galectin-1, Lectin galactoside-binding soluble 1, β-galactoside- binding lectin L-14-I, Lactose-bind
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | P09382 |
---|---|
Calculated MW | 14.5 kDa |
Gene ID | 3956 |
---|---|
Gene Symbol | LGALS1 |
Other Names | Galectin-1, Lectin galactoside-binding soluble 1, β-galactoside- binding lectin L-14-I, Lactose-binding lectin 1, S-Lac lectin 1, Galaptin, 14 kDa lectin, HPL, HBL, Putative MAPK-activating protein PM12, GBP, DKFZp686E23103 |
Gene Source | Human |
Source | E. coli |
Assay&Purity | SDS-PAGE; ≥98% |
Assay2&Purity2 | HPLC; |
Recombinant | Yes |
Results | 2.5 µg/ml |
Target/Specificity | Galectin-1 |
Application Notes | Reconstitute in H₂O to a concentration of 0.1-1.0 mg/ml. This solution can then be diluted into other aqueous buffers and stored at 4°C for 1 week or –20°for future use. |
Format | Lyophilized protein |
Storage | -20°C; Sterile filtered and lyophilized from 20 mM Tris, pH 7.5. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Galectin-1 belongs to growing family of evolutionary conserved animal lectins. Galectins consists of β-galactoside binding lectins that contain homologous carbohydrate recognition domains (CRDs). Galectin-1 has the ability to induce apoptosis of activated T-cells and T-leukaemia cell lines. Other activities include cell differentiation and inhibition activity of CD45 protein phosphatase activity. Galectin also binds β-galactoside as well as CD45, CD3 and CD4. Recombinant Human Galectin is a 14.5 kDa protein consisting of 134 amino acid residues.
References
Hirabayashi J.,et al.Biochim. Biophys. Acta 1008:85-91(1989).
Couraud P.-O.,et al.J. Biol. Chem. 264:1310-1316(1989).
Abbott W.M.,et al.Biochem. J. 259:291-294(1989).
Than N.G.,et al.Proc. Natl. Acad. Sci. U.S.A. 105:15819-15824(2008).
Gitt M.A.,et al.Biochemistry 30:82-89(1991).
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.